Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | AMX-500 |
Synonyms | |
Therapy Description |
Limited information is currently available on AMX-500 (SAR446329) (Sep 2023). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
AMX-500 | AMX500|AMX 500|SAR446329|SAR-446329|SAR 446329 | Limited information is currently available on AMX-500 (SAR446329) (Sep 2023). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT05997615 | Phase Ib/II | AMX-500 | Safety, Pharmacokinetics, and Preliminary Efficacy of AMX-500 in Metastatic Castration Resistant Prostate Cancer (mCRPC) | Recruiting | GBR | ESP | AUS | 0 |